How Synthetic DNA Can Help Combat Antibiotic Resistance

Posted by Nat Connors on 11/30/16 11:30 AM

Antibiotic resistance is a growing problem in our world. Devin Leake, Vice President of Research and Development at Gen9, weighs in on how synthetic biology--and specifically long-length synthetic DNA constructs--can combat the issue of antibiotic resistance.

Read More

Topics: Synthetic Biology, Gene Synthesis, DNA Synthesis

G-Prize Check-in: How Industrial Microbes Used 500kb of Synthetic DNA

Posted by Nat Connors on 11/15/16 11:00 AM
We caught up with Noah Helman, co-founder and Chief Scientific Officer at Industrial Microbes, to learn how the company has utilized the 500kb of synthetic DNA that the company was awarded in the 4th Annual G-Prize competition for synthetic biology.
Read More

Topics: Synthetic Biology, G-Prize, DNA Synthesis

Longest Synthetic Virus Could Be A Breakthrough In Treating Canine Cancer

Posted by Nat Connors on 11/8/16 1:00 PM

“I don’t want to overstate it, but it’s a revolution – a complete revolution,” said Bruce Smith, V.M.D., Ph.D. “Eventually, you will treat cancer patients with chemotherapy and a therapeutic virus that is customized to their tumor. If the tumor were to come back, you would resequence, create a new therapeutic virus, then treat the patient again. It completely changes the way we will manage cancer.”

Read More

Topics: Gene Synthesis, DNA Synthesis

Getting to Breakthroughs Faster with Mass Quantities of Synthetic DNA

Posted by Nat Connors on 8/11/16 10:03 AM
In this video, Patrick Boyle, Head of Design at Ginkgo Bioworks, discusses how mass quantities of synthetic DNA speed his design-build-test cycles and how long-length DNA constructs open up design possibilities in synthetic biology research.
Read More

Topics: Synthetic Biology, Gene Synthesis, DNA Synthesis

The Power of DNA Synthesis: A Video

Posted by Nat Connors on 7/6/16 3:51 PM

A few weeks back, we announced that we'd signed a partnership with Ginkgo Bioworks to deliver 300 million base pairs of DNA through 2017. This unprecedented deal has been thought-provoking in many ways, and we’ve had some great questions arise from the synbio community and beyond. What will Ginkgo do with 300 megabases of content? How can Gen9 manufacture all that DNA? What could I do with pathway-length constructs like the ones Ginkgo uses?

We sat down with leaders at Ginkgo and Gen9 to learn more about what the partnership means for the future of synthetic biology.

Read More

Topics: Synthetic Biology, Gene Synthesis, Clonal, DNA Synthesis, DNA Design

Why the Next Generation of our BioFab® Technology Changes the Game in Gene Synthesis

Posted by Andrew Bond on 4/1/16 3:40 PM

Last week, we announced the next generation of our BioFab® technology, an advancement that enables us to manufacture mass quantities of high quality, long-length, clonal DNA at prices as low as 3 cents per base pair. These game-changing economics will open doors for industrial users as they utilize megabase quantities of DNA on their journey towards new product discovery.

Read More

Topics: Synthetic Biology, Gene Synthesis, Multiplex, DNA Synthesis

Gen9ers Series: Brian Schneider

Posted by Nat Connors on 3/31/16 10:05 AM
Each month, we'll introduce you to a member of the extraordinary Gen9 team, or our Gen9ers (as we affectionately refer to our community). Today, you'll meet Brian Schneider, Director of Strategic Accounts for the Eastern United States. Brian joined the Gen9 team in August of 2015.
Read More

Topics: Synthetic Biology, Gene Synthesis, DNA Synthesis

SynBio Conversations: Dr. Stephen Chambers, CEO of SynbiCITE

Posted by Nat Connors on 3/3/16 12:30 PM
We caught up with Dr. Stephen Chambers, CEO of SynbiCITE, to discuss our recent partnership, learn more about the UK synthetic biology landscape, and talk about the future of the field.
Read More

Topics: Synthetic Biology, DNA Synthesis, SynbiCITE

The Power of Partnership  - Gen9 and SynbiCITE

Posted by Kevin Munnelly on 2/24/16 1:51 PM

Last week, we announced a partnership with SynbiCITE, the UK’s national center for the commercialization of synthetic biology. We’re thrilled to join forces with a visionary organization that is on the forefront of synthetic biology innovation and is opening doors for the next generation of breakthroughs in biology. 

Read More

Topics: Synthetic Biology, Gene Synthesis, DNA Synthesis, SynbiCITE

Multiplex and the Future of DNA Synthesis

Posted by Devin Leake on 2/10/16 4:42 PM

Yesterday, we announced that we've developed new multiplexing technology that will enable us to scale our DNA synthesis platform by nearly two orders of magnitude. With this technology, we'll be able to produce billions of base pairs of DNA at a fraction of today's cost, taking our BioFab® platform to a whole new level. 

Read More

Topics: Synthetic Biology, Gene Synthesis, Multiplex, DNA Synthesis

Start the Conversation

Gen9's Blog

Founded by pioneering scientists in fabrication, genetics, and bio-engineering, the Gen9 vision is one of democratizing synthetic biology. Our goal is to enable broad adoption of powerful synthetic biology techniques by providing custom DNA constructs of the highest possible quality. 

This blog will serve as a platform to:

  • Educate our readers about the goings-on at Gen9
  • Keep our followers up-to-date with service updates and product enhancements
  • Share our views on current events in the Synthetic Biology world

Subscribe to Email Updates